Northern Californias bay area, which includes San Francisco, San Mateo, Santa Clara, Napa, and Marin County, is home to some of the most well-established biopharma companies. The atmosphere is chill, the mood relaxed unless you happen to work for one of these scientific innovators where drive and determination are required to meet the mission.
The Biotech Bay region is home to 3,418 life sciences companies, and 96,574 employees making an average of $151,076. Focuses and technologies range from cell and gene therapy to precision medicine and polymer chemistry, targeting rare diseases along with more pervasive killers. And these seven companies just happen to have a wealth of job openings right now.
Gilead Sciences Inc.
Nestled in Foster City, a small hamlet in San Mateo County, Gilead Sciences is well-known for its achievements in viral diseases, most notably human immunodeficiency virus (HIV).
With a mission of developing novel therapeutics for life-threatening illnesses with unmet medical need, Gilead has an impressive list of FDA-approved medicines. These include Veklury, better known as the COVID-19 therapy, remdesivir, Biktarvy, a single tablet HIV regimen, and Yescarta, a chimeric antigen receptor T cell (CAR-T) drug acquired along with Kite Pharma in 2017.
In 2020, Gilead employed approximately 13,600 individuals. This was an increase of around 2000 (15.25%) from 2019, and the company is growing again.
For those passionate about global access to cancer medicines, Gilead is hiring a Director, Value & Access Strategy Oncology. The successful applicant will have at least 12 years of biopharma experience in market access-related activities bonus points if this is on a regional or country basis. For the more statistically-inclined, Gilead is looking for a Sr. Manager, Biostatistics Oncology.
With well over 300 positions available, opportunities abound to join this Biotech Bay leader.
BioMarin Pharmaceutical Inc.
Established in 1997, San Rafael-based BioMarin specializes in super-rare diseases. BioMarin is targeting cures for diseases like inherited metabolic disorder, Phenylketonuria (PKU), and the rapidly progressing pediatric brain disorder, late infantile neuronal ceroid lipofuscinosis type 2 (CLN2). The company also has a strong presence in hemophilia.
With six commercially approved drugs and a market cap of $15.4 billion, BioMarin was cited by Zacks Equity Research as one of four potential biotech takeover targets for 2021. Whether this will be the case, only time will tell, but BioMarin is getting even bigger, with nearly 200 open posts, including:
Associate Director, Global Brand Management - Strategy and Operations. Anyone wanting to make this strategic career move will need to have a minimum of 7 years of pharmaceutical/biotech industry experience.
Senior Associate - Regulatory Affairs. The successful candidate will possess superior decision-making and problem-solving skills and have a tendency to thrive in a cross-functional business environment. A degree in health or life sciences is required; Ph.D. preferred.
Category Manager, Single Use Technology. This job is for those passionate about supply chain operations, with 5-plus years of strategic procurement experience and 3-plus years in the biotech/life sciences industry. BioMarin would prefer someone with an MBA or MS, and a C.P.M.
Arcus Biosciences, Inc.
Founded in 2015, Arcus Biosciences is combining precision therapeutic strategies in an effort to defeat cancers that have thus far eluded medicine. Arcus has clearly been busy over the past six years, with 13 programs in clinical development and five more coming down the discovery pipeline. Targets include a wide range of cancers, including non-small cell lung cancer (NSCLC), metastatic castration-resistant prostate cancer, and colorectal cancer.
Those seeking a position within this unique biopharma company should check out some of the 90-plus jobs currently available. Here are just a couple:
Bioanalytical Scientist. Arcus is actively recruiting a scientist for its Drug Metabolism and Pharmacokinetics (DMPK) department. Interested candidates with a Ph.D. in pharmaceutical sciences or related disciplines should apply.
Principal Investigator/Clinical Biomarkers Translational Science. Arcus is seeking a candidate with expertise in the development, execution, and oversight of biomarker plans for oncology assets.
Associate Director, Clinical Supply. The winner of this position will play a role in all of Arcuss clinical development problems. The desired applicant will have 7-plus years of relevant experience and a Masters degree.
Global Blood Therapeutics
Global Blood Therapeutics (GBT) is comprised of nearly 400 people driven by the mission of delivering life-changing treatments for those with sickle cell disease (SCD) and other severe blood disorders. In late 2019, the FDA approved GBTs oxbryta (voxelotor) as the first treatment to directly inhibit sickle hemoglobin polymerization, the root cause of SCD. Other investigative medicines include a potential treatment to limit the frequency of vaso-occlusive crises (VOCs) and multiple other shots on goal for SCD.
Located on Oyster Point Boulevard in South San Francisco, GBT is looking for new talent to fill more than 80 positions, including:
Director, Clinical Operations. GBT is open to hiring the right person to work remotely from anywhere in the U.S. for this prime leadership position.
Associate Director, Pharmacovigilance Operations. Another remote opportunity for a vigilant leader with 10 or more years of pharmacovigilance experience in an operational and compliance position.
Nektar Therapeutics
San Francisco-based Nektar Therapeutics is focused on curing cancer and autoimmune disease using polymer chemistry, a unique approach to drug design that uses optimized pharmacology to create new molecular entities.
Nektar is leveraging this technology to develop five clinical-stage investigational drugs with partners Bristol Myers Squibb, Biogen, Eli Lilly & Co., and Vaccibody. The companys lead immuno-oncology candidate, bempegaldesleukin, is an IL-2 pathway agonist designed to stimulate the immune system to fight cancer. It is currently being tested in phase III for a number of indications in combination with BMSs OPDIVO. In February, Nektar inked a co-development deal with SFJ Pharmaceuticals to advance bempegaldesleukin in head and neck cancer.
With all of these programs, it is no wonder Nektar is sourcing new talent for more than 50 positions. Here are just a couple.
Clinical Trial Manager. If any (or all) of the above programs appeal, this role might be the right fit. The successful applicant will have eight years of pharmaceutical development experience, with at least two years overseeing trials.
Principal Medical Science Liaison (MSL)-Northeast. A remote opportunity for a creative, technical, and scientifically-minded individual hailing from the Northeast.
Sangamo Therapeutics, Inc.
This genomic medicine company touches on many of biotechs hottest areas including gene therapy, cell therapy, and in vivo genome editing. Sangamos diverse preclinical and clinical-stage pipeline is aimed at solving life-limiting diseases like Hemophilia A, Amyotrophic lateral sclerosis (ALS), Phenylketonuria (PKU), and Fabry disease.
In July 2020, Sangamo entered into a collaboration with Novartis to develop and commercialize gene regulation therapies for three neurodevelopment targets, including autism spectrum disorder. The agreement leverages Sangamos proprietary genome regulation technology, zinc finger protein transcription factors (ZFP-TFs), which aims to upregulate the expression of genes in these disorders.
Anyone wishing to participate in this mission should check out one of Sangamos available positions. A Research Associate III/IV job is one of many associate-level opportunities currently on the board. There are also openings for a few scientist-level positions, including a Research Scientist, Molecular Biology.
Sana Biotechnology
This cell and gene therapy hybrid is developing its cell engineering platform to deliver any payload to any cell in a specific, predictable and repeatable way. Sana is aiming this technology at a wide range of oncologic, genetic, CNS, and cardiovascular targets in a currently all preclinical pipeline.
Sana has been vocal about its culture of inclusion, diversity and equity (IDE), which leadership believes is paramount to its patient-centric culture. By tapping Head of Development Operations, Farah Anwar, as its IDE leader, Sana has ensured that a senior executive is privy to the people dynamics as well the medical ones.
Sana is currently looking to bring on board a Head of Facilities to spearhead its capital project master plan, a Principal Scientist, Genomics Core to advance this key technology, and a Cloud Systems Administrator to oversee the design.
See the rest here:
Biotech Bay is Rich With Opportunity in the Industry's Hottest Spaces - BioSpace
- Cardiology and Cardiac Pharmacology - April 4th, 2018 [April 4th, 2018]
- EMS Pharmacology: Drugs That Affect the Cardiovascular System ... - April 8th, 2018 [April 8th, 2018]
- EMS Pharmacology: Drugs That Affect the Cardiovascular ... - April 11th, 2018 [April 11th, 2018]
- Cardiology Conferences - Cardiology and Cardiovascular ... - June 5th, 2018 [June 5th, 2018]
- Cardiovascular Pharmacology: Open Access - Open Access ... - June 21st, 2018 [June 21st, 2018]
- CV Pharmacology | Welcome to Cardiovascular Pharmacology ... - July 31st, 2018 [July 31st, 2018]
- Cardiology Conferences | Cardiac pharmacology 2018 ... - September 13th, 2018 [September 13th, 2018]
- Cardiology Conference | Cardiac Pharmacology 2019 ... - November 18th, 2018 [November 18th, 2018]
- Cardiovascular Pharmacology Online Course | Lecturio - November 30th, 2018 [November 30th, 2018]
- Cardiovascular Pharmacology: Open Access - December 16th, 2018 [December 16th, 2018]
- Cardiovascular In vivo Models for Drug Discovery - December 21st, 2018 [December 21st, 2018]
- UTHSC College of Medicine: Department of Pharmacology - February 2nd, 2019 [February 2nd, 2019]
- Department of Pharmacology - School of Medicine - LSU ... - April 5th, 2019 [April 5th, 2019]
- Cardiovascular Pharmacology: Open Access - longdom.org - April 22nd, 2019 [April 22nd, 2019]
- ASPET | Cardiovascular Pharmacology - September 14th, 2019 [September 14th, 2019]
- Pharmacogenomics Market (PGx) Competitive Research And Precise Outlook 2019 To 2025: Astrazeneca, GeneDX, Illumina, Inc., Laboratory Corporation of... - September 18th, 2019 [September 18th, 2019]
- Global and Chinese Microbiome Drugs Market: Industry strategic plan for the period 2019-2024 - Market Report Gazette - September 18th, 2019 [September 18th, 2019]
- Pharmacokinetics Market To Increase at Steady Growth Rate - Commerce Gazette - September 18th, 2019 [September 18th, 2019]
- Moderna Announces Positive Phase 1 Results for the First Systemic Messenger RNA Therapeutic Encoding a Secreted Protein (mRNA-1944) - BioSpace - September 18th, 2019 [September 18th, 2019]
- Janssen to Highlight Depth of Prostate Cancer and Solid Tumor Portfolios with Multiple Data Presentations at ESMO 2019 - Yahoo Finance - September 18th, 2019 [September 18th, 2019]
- Cardiac fibrosis study identifies key proteins that translate into heart disease - BSA bureau - September 18th, 2019 [September 18th, 2019]
- Nitric Oxide: Worldwide Therapeutics & Markets to 2028 with Profiles on 35 Companies & 18 Collaborations Tabulated - Yahoo Finance - September 18th, 2019 [September 18th, 2019]
- Cytokinetics Announces Data From Phase 1 Study of CK-3773274 at the HFSA 23 Annual Scientific Meeting - Yahoo Finance - September 18th, 2019 [September 18th, 2019]
- Is it risky to continue with blood thinner drugs after a gastrointestinal bleed? - Medical News Bulletin - September 18th, 2019 [September 18th, 2019]
- Women urged to exercise and eat well due to cholesterol after menopause - Sydney Morning Herald - September 18th, 2019 [September 18th, 2019]
- Former Executive Director of Preclinical Safety at Novartis, Klaus Peter Hoffmann, MD, PhD, Joins NDA Partners as Expert - Yahoo Finance - September 18th, 2019 [September 18th, 2019]
- Yale alumna Dr. Nancy Brown named dean of Yale School of Medicine - Yale News - September 18th, 2019 [September 18th, 2019]
- Verve Therapeutics Appoints Cardiologist Andrew Bellinger, M.D., Ph.D., as Chief Scientific Officer - Business Wire - October 7th, 2019 [October 7th, 2019]
- G-Protein Coupled Receptors (GPCRs) Market Size And Prediction By Leading Manufacturers According To Its Application And Types Till 2022 - Space... - October 7th, 2019 [October 7th, 2019]
- Best supplements for blood pressure: The natural remedy proven to lower your reading - Express - October 7th, 2019 [October 7th, 2019]
- Advanced Drug Delivery Systems Market Growth Analysis 2019 to Share Key Aspects of the Industry with the details of Influence Factors Forecast to 2024... - October 28th, 2019 [October 28th, 2019]
- The 9 Biggest Technology Trends That Will Transform Medicine And Healthcare In 2020 - Forbes - November 6th, 2019 [November 6th, 2019]
- Potential PF Therapy AD-214 to Move into Phase 1 Testing in Humans - Pulmonary Fibrosis News - November 6th, 2019 [November 6th, 2019]
- Edited Transcript of CYTK earnings conference call or presentation 31-Oct-19 8:30pm GMT - Yahoo Finance - November 6th, 2019 [November 6th, 2019]
- The Montreal Heart Institute celebrates its 500th heart transplant - GlobeNewswire - November 6th, 2019 [November 6th, 2019]
- Latest Research Report to uncover key Factors of Global Cardiovascular Repair And Reconstruction Devices Market - Market Research Base - November 6th, 2019 [November 6th, 2019]
- Global Cardiovascular Repair And Reconstruction Devices Market: Development History, Current Analysis and Estimated Forecast to 2025 - Market Research... - November 29th, 2019 [November 29th, 2019]
- The cardiac safety services market is projected to reach USD 752 million by 2024 from USD 442 million in 2019, at a CAGR of 11.2% - Yahoo Finance - December 11th, 2019 [December 11th, 2019]
- Evaluation of the Effect of Fish Oil Alone and in Combination with a P | DMSO - Dove Medical Press - January 13th, 2020 [January 13th, 2020]
- Amarin's Multiple Positives And Other News: The Good, Bad, And Ugly Of Biopharma - Seeking Alpha - January 25th, 2020 [January 25th, 2020]
- Heres What We Know About CBDs Effects On Varicose Veins - The Fresh Toast - January 28th, 2020 [January 28th, 2020]
- Hypertension: This Spice Can Help You Control High Blood Pressure Easily And Effectively - Doctor NDTV - January 28th, 2020 [January 28th, 2020]
- Cannabis Manual: Better Together - Weekly Alibi - January 30th, 2020 [January 30th, 2020]
- Pharmacology: Cardiovascular Drugs 1 (30 Items) - Nurseslabs - March 1st, 2020 [March 1st, 2020]
- A central master driver of psychosocial stress responses in the rat - Science Magazine - March 9th, 2020 [March 9th, 2020]
- The Global Cardiac Safety Services Market is expected to grow from USD 419.45 Million in 2018 to USD 865.23 Million by the end of 2025 at a Compound... - March 29th, 2020 [March 29th, 2020]
- Milestone Pharmaceuticals Announces Topline Results from First-of-its-kind Phase 3 NODE-301 Trial of Etripamil for At-home Acute PSVT Treatment -... - March 29th, 2020 [March 29th, 2020]
- Fresh Produce In Short Supply? Prioritize This Veggie In Your Diet - mindbodygreen.com - April 25th, 2020 [April 25th, 2020]
- COVID-19: What's RNA research got to do with it? - University of Rochester - May 1st, 2020 [May 1st, 2020]
- What Happens When You Add Other Drugs To Your LSD Trip? - VICE - May 1st, 2020 [May 1st, 2020]
- Toward a Pharmacology of Resolution - Harvard Magazine - May 1st, 2020 [May 1st, 2020]
- GLYCOMIMETICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q) - marketscreener.com - May 2nd, 2020 [May 2nd, 2020]
- This Simple Breathing Advice From A Nobel Prize Winner Can Turn The Tables On Stress During The Coronavirus Lockdown - Forbes - May 2nd, 2020 [May 2nd, 2020]
- National Nurses Week 2020: What Experiences Have Shaped Your Nursing Career? - HealthLeaders Media - May 2nd, 2020 [May 2nd, 2020]
- Research Paper Stresses Importance of Repurposing Drugs Against COVID-19 - BioSpace - May 13th, 2020 [May 13th, 2020]
- Repurposing existing drugs to treat coronavirus will likely be quicker than a vaccine, scientists claim - CNBC - May 13th, 2020 [May 13th, 2020]
- Alzheimer's and Cannabis - Greenway - Greenway - May 18th, 2020 [May 18th, 2020]
- Moderna Highlights Advances in Platform Science and Innovative Vaccine Research at Third Annual Science Day - Business Wire - June 2nd, 2020 [June 2nd, 2020]
- Healthy people shouldn't take daily aspirin to prevent heart disease, review finds - WDJT - June 6th, 2020 [June 6th, 2020]
- Study reveals how living close to roadways may impact the brain - Drew Reports News - June 18th, 2020 [June 18th, 2020]
- Disruptions in circadian rhythms not only cause sleep disorders, but could also put you at risk of these... - Firstpost - June 18th, 2020 [June 18th, 2020]
- NeonMind Files Patent Application for Therapeutic Use of DMT - Yahoo Finance - June 18th, 2020 [June 18th, 2020]
- Vitamin D What you need to know about the sunshine vitamin - Medical News Bulletin - July 9th, 2020 [July 9th, 2020]
- Idorsia announces positive results in the second Phase 3 study of daridorexant - GlobeNewswire - July 9th, 2020 [July 9th, 2020]
- ATAI Life Sciences takes on opioid crisis by acquiring Kures to develop novel therapeutics for opioid abuse - PRNewswire - July 9th, 2020 [July 9th, 2020]
- Drug Discovery Outsourcing Market Highly Favorable with new Demand to the Growth Rate by 2027| Thermo Fisher Scientific, Merck KGaA, Albany Molecular... - August 21st, 2020 [August 21st, 2020]
- Bringing Peer Review To Early COVID-19 Research, More News - Bio-IT World - August 21st, 2020 [August 21st, 2020]
- Cardiac Safety Services Market Research Report by Type of Service, by Type, by End User - Global Forecast to 2025 - Cumulative Impact of COVID-19 -... - August 21st, 2020 [August 21st, 2020]
- UCI study finds women with diabetes and high levels of coronary artery calcium at greater risk of death than men - Newswise - August 21st, 2020 [August 21st, 2020]
- Globa Advanced Drug Delivery Systems Market 2020 Research, Key Players, Industry Overview, Supply and Consumption Analysis 2024 - Bulletin Line - September 2nd, 2020 [September 2nd, 2020]
- Esperion Announces Two Data Presentations of NEXLETOL (bempedoic acid) Tablet at the ESC Congress 2020 - GlobeNewswire - September 2nd, 2020 [September 2nd, 2020]
- Women with diabetes and high levels of coronary artery calcium at greater risk of death than men - UCI News - September 2nd, 2020 [September 2nd, 2020]
- 15 Clever Ways to Use Leftover Red Wine - Yahoo Lifestyle - September 2nd, 2020 [September 2nd, 2020]
- UK Study Leads to Better Understanding of Blood Pressure Regulation, Atherosclerosis - UKNow - September 2nd, 2020 [September 2nd, 2020]
- Academic always top of the class for pay and conditions - Extra.ie - September 15th, 2020 [September 15th, 2020]
- Cardiac Safety Services Market Size Is Rising Tremendously Due To Increasing Need of Healthcare Services Centralization Till 2025 - TC BizNews - September 15th, 2020 [September 15th, 2020]
- 5 Benefits of Berberine, Including Why It's a Healthy Gut All-Star - msnNOW - September 15th, 2020 [September 15th, 2020]
- Advanced Drug Delivery Systems Market 2020 Report Covers Key Growth Factors, Global Trends, Opportunities by Regions, Industry Size and Share... - September 23rd, 2020 [September 23rd, 2020]
- Janssen Presents Findings from Global, Multi-Center Trial Examining Amivantamab in Combination with Lazertinib in Patients with EGFR-Mutated Non-Small... - September 23rd, 2020 [September 23rd, 2020]
- MASSIVE GROWTH OF DRUG DISCOVERY SERVICES MARKET WILL RAISE USD 19.1 BILLION BY 2027, CAGR +13% FROM 2020 TO 2027 WITH TOP KEY PLAYERS LIKE THERMO... - September 29th, 2020 [September 29th, 2020]